| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 533.6K | $5.97M | - | |
| Other | 201.6K | $2.25M | - | |
| Other | 199.7K | $2.23M | - | |
| CFO | 194.4K | $2.17M | - | |
| Other | 78.3K | $875.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2019 | Coffin Robert61 | President And CEO | Sell | 48,500 | $17.01 | $824,985.00 | -1.1% | |
| Nov 6, 2019 | Astley-Sparke Philip47 | Executive Chairman | Sell | 29,000 | $17.01 | $493,290.00 | -1.1% | |
| Nov 6, 2019 | Love Colin72 | Chief Operating Officer | Sell | 22,500 | $17.01 | $382,725.00 | -1.1% | |
| Nov 4, 2019 | Love Colin72 | Chief Operating Officer | Sell | 22,500 | $17.03 | $383,085.00 | -1.0% | |
| Nov 4, 2019 | Astley-Sparke Philip47 | Executive Chairman | Sell | 29,000 | $17.03 | $493,754.00 | -1.0% | |
| Nov 4, 2019 | Coffin Robert61 | President And CEO | Sell | 48,500 | $17.03 | $825,761.00 | -1.0% | |
| Oct 31, 2019 | Astley-Sparke Philip47 | Executive Chairman | Sell | 14,500 | $17.00 | $246,500.00 | -1.0% | |
| Oct 31, 2019 | Love Colin72 | Chief Operating Officer | Sell | 11,250 | $17.00 | $191,250.00 | -1.0% | |
| Oct 31, 2019 | Coffin Robert61 | President And CEO | Sell | 24,250 | $17.00 | $412,250.00 | -1.0% | |
| Sep 23, 2019 | Coffin Robert61 | President And CEO | Sell | 24,250 | $17.05 | $413,462.50 | -1.0% |